Pharmacodynamics Clinical Trial
Official title:
KF2023#1-Trial: Influence of Statin Intake on Cellular Readouts
A majority of high-risk patients does not achieve their cholesterol target levels and most of these patients do not receive more effective combination therapy, which goes beyond statin monotherapy. Large interindividual differences in treatment outcomes have been observed for patients receiving statins. Statins block cholesterol synthesis and increase cellular low-density lipoprotein (LDL) uptake. Importantly, LDL uptake is highly divergent in individuals.The aim of this trial is to investigate how atorvastatin influences leukocyte readouts of LDL uptake and lipid storage in humans. The trial is a single-arm, open-label, interventional trial. A total of 15 healthy volunteers will receive 40 mg atorvastatin once a day for 4 weeks. The participants will provide blood samples before starting the atorvastatin intervention, each week when taking atorvastatin, and one week after the end of the intervention for the measurement of leukocyte readouts of LDL uptake and lipid storage.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02532998 -
A Study to Assess the Pharmacodynamic Effect of Single Doses of AZD9977 in Healthy Male Subjects
|
Phase 1 | |
| Completed |
NCT01214941 -
Effect of Itraconazole and Ticlopidine on the Pharmacokinetics and Pharmacodynamics of Oral Tramadol
|
Phase 4 | |
| Completed |
NCT00754871 -
Pharmacodynamic Characterization of Dienogest
|
Phase 1 | |
| Completed |
NCT06072170 -
Single Ascending Doses of Kratom in Healthy Nondependent Adults With Opioid Experience
|
Phase 1 | |
| Completed |
NCT02306915 -
PK, PD, Safety and Tolerability of Lipegfilgrastim in Healthy Japanese and Caucasian Participants
|
Phase 1 | |
| Completed |
NCT01158755 -
Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study
|
Phase 2 | |
| Completed |
NCT05005520 -
Study of DTRI-031 in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT03337581 -
Pharmacodynamics and Pharmacokinetics of Dexmedetomidine in Pediatric
|
Phase 4 | |
| Completed |
NCT03895229 -
The Effect of Morning Versus Evening Administration on The Pharmacokinetics and Pharmacodynamics of Empagliflozin
|
Phase 1 | |
| Recruiting |
NCT05153837 -
Effect of Oral Water in Healthy Volunteers on Cardiac Output, Regional Flow and Microcirculation in Healthy Volunteers
|
N/A | |
| Completed |
NCT01954589 -
Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-462206
|
Phase 1 | |
| Withdrawn |
NCT01214122 -
A Drug-Drug Interaction Study Between AZD9668 and Warfarin to Study the Effect of AZD9668 on the Metabolism and Effect of Warfarin
|
Phase 1 | |
| Completed |
NCT02512575 -
A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567.
|
Phase 1 | |
| Active, not recruiting |
NCT04911270 -
Clinical Decision Support Tool for Vancomycin Dosing in Children
|
N/A | |
| Recruiting |
NCT03161002 -
Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Ticagrelor
|
||
| Completed |
NCT05795192 -
SB17170 Phase1 Trial in Healthy Volunteer
|
Phase 1 | |
| Recruiting |
NCT03530228 -
A Phase 1 Study of Tegoprazan on Healthy Male Volunteers
|
Phase 1 | |
| Completed |
NCT02308748 -
Ability of Late Sodium or Calcium Current Block to Balance the ECG Effects of Potassium Current Block
|
Phase 1 | |
| Completed |
NCT05716854 -
Electrophysiological Effects of Potential QT Prolonging Drugs
|
Phase 1 | |
| Not yet recruiting |
NCT05764356 -
Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II
|